These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28815732)

  • 1. Antibacterial and β-Lactamase Inhibitory Activity of Monocyclic β-Lactams.
    Decuyper L; Jukič M; Sosič I; Žula A; D'hooghe M; Gobec S
    Med Res Rev; 2018 Mar; 38(2):426-503. PubMed ID: 28815732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic design of beta-lactam antibiotics: penams and analogues and monocyclic beta-lactams.
    Ekström B
    Scand J Infect Dis Suppl; 1984; 42():38-49. PubMed ID: 6335599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyclic beta-lactams for therapeutic uses: a patent overview (2010-2020).
    Grabrijan K; Strašek N; Gobec S
    Expert Opin Ther Pat; 2021 Mar; 31(3):247-266. PubMed ID: 33327805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugates of monocyclic β-lactams and siderophore mimetics: a patent evaluation (WO2023023393).
    Krajnc A; Gobec S
    Expert Opin Ther Pat; 2023; 33(7-8):471-476. PubMed ID: 37902072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyclic β-lactams: new structures for new biological activities.
    Galletti P; Giacomini D
    Curr Med Chem; 2011; 18(28):4265-83. PubMed ID: 21861821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward inhibitors of metallo-β-lactamases.
    McGeary RP; Tan DT; Schenk G
    Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugation of Aztreonam, a Synthetic Monocyclic β-Lactam Antibiotic, to a Siderophore Mimetic Significantly Expands Activity Against Gram-Negative Bacteria.
    Liu R; Miller PA; Miller MJ
    ACS Infect Dis; 2021 Nov; 7(11):2979-2986. PubMed ID: 34668698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of efficacious Pseudomonas aeruginosa-targeted siderophore-conjugated monocarbams by application of a semi-mechanistic pharmacokinetic/pharmacodynamic model.
    Murphy-Benenato KE; Bhagunde PR; Chen A; Davis HE; Durand-Réville TF; Ehmann DE; Galullo V; Harris JJ; Hatoum-Mokdad H; Jahić H; Kim A; Manjunatha MR; Manyak EL; Mueller J; Patey S; Quiroga O; Rooney M; Sha L; Shapiro AB; Sylvester M; Tan B; Tsai AS; Uria-Nickelsen M; Wu Y; Zambrowski M; Zhao SX
    J Med Chem; 2015 Mar; 58(5):2195-205. PubMed ID: 25658376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Antibacterial Activities of Amidine Substituted Monocyclic β-Lactams.
    Zhai L; He L; Liu Y; Myo KK; Iqbal Z; Sun J; Ji J; Ji J; Mu Y; Gao Y; Tang D; Yang H; Yang Z
    Med Chem; 2022; 18(5):574-588. PubMed ID: 34463230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of beta-lactamases from Enterobacter cloacae by monophosphams.
    Bush K; Smith SA; Tanaka SK; Bonner DP
    J Antimicrob Chemother; 1988 Dec; 22(6):801-9. PubMed ID: 3266620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-lactam antibiotics: An overview from a medicinal chemistry perspective.
    Lima LM; Silva BNMD; Barbosa G; Barreiro EJ
    Eur J Med Chem; 2020 Dec; 208():112829. PubMed ID: 33002736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure activity relationships among the monobactams.
    Bonner DP; Sykes RB
    J Antimicrob Chemother; 1984 Oct; 14(4):313-27. PubMed ID: 6389473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses and studies of new forms of N-sulfonyloxy β-lactams as potential antibacterial agents and β-lactamase inhibitors.
    Carosso S; Miller MJ
    Bioorg Med Chem; 2015 Sep; 23(18):6138-47. PubMed ID: 26321604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactamases and beta-lactamase inhibitors.
    Williams JD
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S3-7; discussion S26-7. PubMed ID: 10526867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyclic β-lactams loaded on hydroxyapatite: new biomaterials with enhanced antibacterial activity against resistant strains.
    Giacomini D; Torricelli P; Gentilomi GA; Boanini E; Gazzano M; Bonvicini F; Benetti E; Soldati R; Martelli G; Rubini K; Bigi A
    Sci Rep; 2017 Jun; 7(1):2712. PubMed ID: 28578416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyclic β-lactams as antibacterial agents: facing antioxidant activity of N-methylthio-azetidinones.
    Cervellati R; Galletti P; Greco E; Cocuzza CE; Musumeci R; Bardini L; Paolucci F; Pori M; Soldati R; Giacomini D
    Eur J Med Chem; 2013 Feb; 60():340-9. PubMed ID: 23314047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of formylamino- and methoxy-substituted beta-lactam antibiotics with beta-lactamases.
    Okonogi K; Sugiura A; Kuno M; Ono H; Harada S; Higashide E
    J Antibiot (Tokyo); 1985 Nov; 38(11):1555-63. PubMed ID: 3878359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azetidinone-isothiazolidinones: stereoselective synthesis and antibacterial evaluation of new monocyclic beta-lactams.
    Cerić H; Sindler-Kulyk M; Kovacević M; Perić M; Zivković A
    Bioorg Med Chem; 2010 May; 18(9):3053-8. PubMed ID: 20382539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to beta-lactam antibiotics: structure and mechanism based design of beta-lactamase inhibitors.
    Sandanayaka VP; Prashad AS
    Curr Med Chem; 2002 Jun; 9(12):1145-65. PubMed ID: 12052169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-(Sulfamoylbenzoyl)-L-proline Derivatives as Potential Non-β-lactam ESBL Inhibitors: Structure-Based Lead Identification, Medicinal Chemistry and Synergistic Antibacterial Activities.
    Liu X; Dong S; Ma Y; Xu H; Zhao H; Gao Q
    Med Chem; 2019; 15(2):196-206. PubMed ID: 30112996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.